Ryo Kurita
- Genetics top 0.5%
- Hemoglobinopathies and Related Disorders 34
- Virus-based gene therapy research 9
- Hematology top 1%
- Blood groups and transfusion 9
- Molecular Biology top 5%
- CRISPR and Genetic Engineering 22
- RNA modifications and cancer 17
- Epigenetics and DNA Methylation 12
-
- Prenatal Screening and Diagnostics 12
-
- Erythrocyte Function and Pathophysiology 29
- Co-authors
- Yukio NakamuraDaniel E. BauerFalak SherStuart H. OrkinMerlin CrossleyGuo‐Cheng YuanKenzaburo TaniGabriella E. Martyn
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ryo Kurita
81 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Genetics 1.5k
- Hematology 707
- Business and International Management 89
- Molecular Biology 2.5k
- Pediatrics, Perinatology and Child Health 478
Countries citing papers authored by Ryo Kurita
This map shows the geographic impact of Ryo Kurita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Kurita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Kurita more than expected).
Fields of papers citing papers by Ryo Kurita
This network shows the impact of papers produced by Ryo Kurita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Kurita. The network helps show where Ryo Kurita may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryo Kurita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 13 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 13 | |
| 9 | 2019 | 55 | |
| 10 | 2018 | 17 | |
| 11 | 2018 | 145 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 71 | |
| 14 | 2017 | 132 | |
| 15 | BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis | 2015 | 2 |
| 16 | 2014 | 43 | |
| 17 | 2013 | 273 | |
| 18 | 2010 | 6 | |
| 19 | 2006 | 17 | |
| 20 | 2004 | 2 |
About Ryo Kurita
Ryo Kurita is a scholar working on Genetics, Hematology and Physiology, having authored 83 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (34 papers), Erythrocyte Function and Pathophysiology (29 papers), CRISPR and Genetic Engineering (22 papers), RNA modifications and cancer (17 papers), Epigenetics and DNA Methylation (12 papers), Prenatal Screening and Diagnostics (12 papers), Virus-based gene therapy research (9 papers) and Blood groups and transfusion (9 papers). The work is most often cited by research in Genetics (1.5k citations), Hematology (707 citations) and Business and International Management (89 citations). Ryo Kurita has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yukio Nakamura, Daniel E. Bauer, Falak Sher, Stuart H. Orkin, Merlin Crossley, Guo‐Cheng Yuan, Kenzaburo Tani, Gabriella E. Martyn, Matthew C. Canver and Takahiro Maeda. Their work appears in journals such as Blood, Haematologica, Blood Advances, Transfusion and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.